Abstract
A simple, precise, rapid, and low-cost conductometric method for verapamil hydrochloride determination in pharmaceutical formulations is described. Verapamil present in pharmaceuticals containing known quantities of the drug was conductometrically titrated in aqueous solution with silver nitrate using a conductometric cell coupled to an autotitrator. The method is based on the precipitation of chloride ions coming from verapamil hydrochloride with Ag(I) ions yielding AgCl(s) and the conductance of the solution is measured as a function of the volume of titrant. Under optimized experimental conditions the method was applied with success for verapamil determination in three pharmaceutical formulations in the concentration level of 1.00 x 10-2 mol L-1. The relative standard deviation for six successive measurements was smaller than 0.5 % and no interferences were observed in the presence of common components of the tablets such as sodium monophosphate, magnesium stearate and lactose. Recoveries of verapamil from various tablet dosage formulations ranging from 97.1 to 102.8% were obtained. These results are in good accordance with the declared values of manufacturer and an official method based on spectrophotometric analysis.
Keywords: Verapamil hydrochloride, Conductometric titration, Pharmaceutical formulations, HPLC, Capillary electrophoresis, Atomic emission spectrometry, Matrix effect, Precision, Recovery, Selectivity
Current Pharmaceutical Analysis
Title: A Fast and Simple Conductometric Method for Verapamil Hydrochloride Determination in Pharmaceutical Formulations
Volume: 7 Issue: 4
Author(s): Fabio R. Caetano, Ava Gevaerd, Marcio F. Bergamini and Luiz H. Marcolino
Affiliation:
Keywords: Verapamil hydrochloride, Conductometric titration, Pharmaceutical formulations, HPLC, Capillary electrophoresis, Atomic emission spectrometry, Matrix effect, Precision, Recovery, Selectivity
Abstract: A simple, precise, rapid, and low-cost conductometric method for verapamil hydrochloride determination in pharmaceutical formulations is described. Verapamil present in pharmaceuticals containing known quantities of the drug was conductometrically titrated in aqueous solution with silver nitrate using a conductometric cell coupled to an autotitrator. The method is based on the precipitation of chloride ions coming from verapamil hydrochloride with Ag(I) ions yielding AgCl(s) and the conductance of the solution is measured as a function of the volume of titrant. Under optimized experimental conditions the method was applied with success for verapamil determination in three pharmaceutical formulations in the concentration level of 1.00 x 10-2 mol L-1. The relative standard deviation for six successive measurements was smaller than 0.5 % and no interferences were observed in the presence of common components of the tablets such as sodium monophosphate, magnesium stearate and lactose. Recoveries of verapamil from various tablet dosage formulations ranging from 97.1 to 102.8% were obtained. These results are in good accordance with the declared values of manufacturer and an official method based on spectrophotometric analysis.
Export Options
About this article
Cite this article as:
R. Caetano Fabio, Gevaerd Ava, F. Bergamini Marcio and H. Marcolino Luiz, A Fast and Simple Conductometric Method for Verapamil Hydrochloride Determination in Pharmaceutical Formulations, Current Pharmaceutical Analysis 2011; 7 (4) . https://dx.doi.org/10.2174/157341211797458041
DOI https://dx.doi.org/10.2174/157341211797458041 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Energy Remodeling, Mitochondrial Disorder and Heart Failure
Current Pharmaceutical Design Indications of Anti-Inflammatory Drugs in Cardiac Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Intra-Renal Hemodynamic Changes After Habitual Physical Activity in Patients with Chronic Kidney Disease
Current Pharmaceutical Design Value of Real Time Three Dimensional Transesophageal Echocardiography in General Cardiology Practice
Recent Patents on Medical Imaging Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
Current Pharmaceutical Design Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice
Current Drug Safety Inhibitors of Chronically Active Ras: Potential for Treatment of Human Malignancies
Recent Patents on Anti-Cancer Drug Discovery HIV-1-Infected Long-Term Non-Progressors have Milder Mitochondrial Impairment and Lower Mitochondrially-Driven Apoptosis in Peripheral Blood Mononuclear Cells than Typical Progressors
Current HIV Research Strategy for a Genetic Assessment of Antipsychotic and Antidepressant- Related Proarrhythmia
Current Medicinal Chemistry Proteomics to Identify Novel Biomarkers and Therapeutic Targets in Cardiovascular Disease
Letters in Drug Design & Discovery Anti-inflammatory Treatment of Acute Coronary Syndromes
Current Pharmaceutical Design Sacubitril/Valsartan: A New Dawn has Begun! A Revisited Review
Current Cardiology Reviews Anesthetic Pharmacology and Perioperative Considerations for Heart Transplantation
Current Clinical Pharmacology Prevalence of Dilated Cardiomyopathy in HIV-Infected African Patients Not Receiving HAART: A Multicenter, Observational, Prospective, Cohort Study in Rwanda
Current HIV Research Treatment of Takotsubo Cardiomyopathy
Current Pharmaceutical Design Left Ventricular Non-compaction: From Recognition to Treatment
Current Pharmaceutical Design Glucocorticoid Analogues: Potential Therapeutic Alternatives for Treating Inflammatory Muscle Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Anemia and Chronic Kidney Disease: Making Sense of the Recent Trials
Reviews on Recent Clinical Trials The PKB/AKT Pathway in Cancer
Current Pharmaceutical Design Impact of COVID-19 Infection on Maternal and Neonatal Outcomes: A Review of 11078 Pregnancies Reported in the Literature
Current Women`s Health Reviews